United Therapeutics Corporation
UTHR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,195 | $985 | $727 | $476 |
| Dep. & Amort. | $73 | $53 | $51 | $50 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $144 | $39 | $107 | $139 |
| Change in WC | -$60 | -$98 | -$141 | -$174 |
| Other Non-Cash | -$24 | -$1 | $58 | $108 |
| Operating Cash Flow | $1,327 | $978 | $803 | $598 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$247 | -$230 | -$139 | -$121 |
| Net Acquisitions | -$31 | -$89 | -$2 | $0 |
| Inv. Purchases | -$1,646 | -$2,514 | -$1,709 | -$1,895 |
| Inv. Sales/Matur. | $2,369 | $2,137 | $1,034 | $1,529 |
| Other Inv. Act. | -$29 | -$23 | $4 | $0 |
| Investing Cash Flow | $417 | -$720 | -$812 | -$487 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$400 | -$100 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$1,012 | -$14 | -$11 | -$11 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $157 | $102 | $87 | $56 |
| Financing Cash Flow | -$1,255 | -$12 | $75 | $45 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $490 | $247 | $66 | $156 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,208 | $961 | $895 | $739 |
| End Cash | $1,697 | $1,208 | $961 | $895 |
| Free Cash Flow | $1,081 | $748 | $664 | $477 |